Bayhill Therapeutics Overview
Bayhill Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Through a targeted and selective approach, the Company’s product candidates are designed to restore the immune system to its normal state, known as “tolerance,” by eliminating specific,...More»
Bayhill Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA™ platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Through a targeted and selective approach, the Company’s product candidates are designed to restore the immune system to its normal state, known as “tolerance,” by eliminating specific, harmful immune responses while leaving the rest of the immune system intact.«Less
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| Unknown | Series A | Unknown | Unknown | |
| 2006 | Series C | 15.8M | Unknown |
|
| 04/06/2006 | Series B | 15.8M | Unknown |
|
Products
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.

loading...
Profile
Opinions
